Given the established role of cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor alpha in the pathophysiology of heart failure, it is plausible that the symptomatic relief associated with MSCs may be, at least partly, secondary to their immunomodulatory capacity [60]. This evidence concerns the gene TNF and heart failure.